HuagongsheHuagongshe Chemistry Print Report · For research reference only
Lithium Hydroxide → HCID 90030331, compound
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | Lithium Hydroxide | HCID 3939 | — |
| Reactant | HCID 118523923 | HCID 118523923 | — |
| Reactant | 3-(1-(3-fluorobenzyl)-1H-pyrazol-4-yl)-5-(4-(piperidin-4-yl)phenyl)-1-tosyl-1H-pyrrolo[2,3-b]pyridine hydrochloride | HCID 118524085 | — |
| Solvent | Methanol tetrahydrofuran water | HCID 21892291 | — |
| Product | HCID 90030331 | HCID 90030331 | 45% |
Reaction Steps
Using similar reaction conditions as described in step-iii of example-1, 5-(4-(4-methylpiperazin-1-yl)phenyl)-3-(1-phenethyl-1H-pyrazol-4-yl)-1-tosyl-1H-pyrrolo[2,3-b]pyridine (60 mg, 0.097 mmol) was hydrolyzed by lithium hydroxide (12 mg, 0.291 mmol) in THF/methanol/water (1/1/1 ml) to afford 20 mg (45.0% yield) of the titled compound. 1H NMR (CD3OD, 400 MHz): δ 8.24 (s, 1H), 7.88 (s, 1H), 7.78 (s, 1H), 7.67-7.65 (d, 2H), 7.61 (s, 1H), 7.28-7.15 (m, 6H), 4.49-4.45 (t, 2H), 4.00-3.97 (d, 2H), 3.69-3.66 (d, 2H), 3.23-3.12 (m, 6H), 3.02 (s, 3H). MS: m/z=462.9 (M+1), HPLC: 96.28% in method B.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US09353107B2 |
| Source dataset | uspto-grants-2016_05 |
| ORD ID | ord-11fdadcea10546cf82844906085eb0d0 |
| Source note | uspto-grants-2016_05 |